Medical equipment maker Revvity on Monday joined larger peers in warning about the impact of tariffs imposed by the U.S.

Thermo Fisher Scientific reported better-than-expected profit and revenue for the first quarter on Wednesday, helped by ...

Thermo Fisher Scientific is employing an enhanced platform technology and a new CHO K-1 cell line that can reduce timelines ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

Thermo Fisher's updated 2025 guidance shows a $1 EPS, or 4.2% hit from tariffs and government spending cuts. Read why I ...

Thermo Fisher Scientific Inc. (Waltham, Mass.) will invest an additional $2 billion in the United States over the next four years, strengthening American innovation, manufacturing and economic ...

Investment includes $1.5 billion in capital expenditures to expand manufacturing and $500 million dedicated to R&D focused on ...

Return on Equity (ROE): Thermo Fisher Scientific's financial strength is reflected in its exceptional ROE, which exceeds ...

Thermo Fisher Scientific’s proposal to build a new corporate aircraft hangar and office at Pease in Portsmouth gains approval ...

Thermo Fisher Scientific and Danaher are projecting that their sales to academic and government (A&G) customers will shrink ...

Company management said they expect the tariff battle with China to cause weakening of $375 million in adjusted operating ...